Chem
J-GLOBAL ID:200907099086874861   Nikkaji number:J302.598E

Sarmesin

サルメシン
Substance type:
Substance type
Substance type classified into 3 categories.
Decided structure: Substances with a clear structure
Undicided Structure: Substances with unknown or undetermined structure
Mixtures: Mixtures, racemic compounds, or compounds with relative structural arrangements
Decided structure
Molecular formula: C50H73N13O10
Molecular formula furigana: C50-H73-N13-O10
Molecular weight: 1016.215
InChI: InChI=1S/C50H73N13O10/c1-7-30(4)42(47(69)59-37(25-33-26-54-28-56-33)48(70)63-22-12-16-39(63)45(67)60-38(49(71)72)24-31-13-9-8-10-14-31)62-44(66)36(23-32-17-19-34(73-6)20-18-32)58-46(68)41(29(2)3)61-43(65)35(57-40(64)27-53-5)15-11-21-55-50(51)52/h8-10,13-14,17-20,26,28-30,35-39,41-42,53H,7,11-12,15-16,21-25,27H2,1-6H3,(H,54,56)(H,57,64)(H,58,68)(H,59,69)(H,60,67)(H,61,65)(H,62,66)(H,71,72)(H4,51,52,55)/t30-,35-,36-,37-,38-,39-,41-,42-/m0/s1
InChI key: WJXAVNPIJIPGMN-PNGYUKAISA-N
SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
Systematic name  (4):
  • N-メチルGly-L-Arg-L-Val-O-メチル-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-OH
  • Sar-L-Arg-L-Val-O-メチル-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-OH
  • (2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-5-カルバムイミドアミド-2-[2-(メチルアミノ)アセトアミド]ペンタンアミド]-3-メチルブタンアミド]-3-(4-メトキシフェニル)プロパンアミド]-3-メチルペンタンアミド]-3-(1H-イミダゾール-4-イル)プロパノイル]ピロリジン-2-イル]ホルムアミド}-3-フェニルプロパン酸
  • (2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[2-(methylamino)acetamido]pentanamido]-3-methylbutanamido]-3-(4-methoxyphenyl)propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid
Other name (9):
  • Sar-L-Arg-L-Val-O-Methyl-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-OH
  • サルメシン
  • Sarmesin
  • [Sar1,Tyr(Me)4]アンギオテンシンII
  • [Sar1,Tyr(Me)4]angiotensin II
Show all
Application (3):
Angiotensin II ,  angiotensin antagonist ,  hypotensive drug
Thsaurus map:

Return to Previous Page